Surveillance Summary Feb 7 – Feb 13, 2004
February 13, 2004 by admin · Leave a Comment
Our surveillance program experienced moderate activity throughout week 7 of 2004. A total of 19 technology updates were recorded; 12 of these were new technologies added to our database, while the remaining 7 updates occurred for already existing technology records. Etanercept, Remicade and Visudyne were the only High Impact technologies updated during week 7. Please note that Erbitux, previously designated as Moderate Impact, was elevated to our High Impact designation.
